Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2023-06-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
关于特定股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the release of pledged shares by a specific shareholder. It details the number of shares released from pledge, the shareholder involved, and the status of pledged shares. There is no financial report, earnings data, or management discussion. The document is short (1073 characters) and serves as a regulatory disclosure about share pledge status changes. This fits the category of a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-21 Chinese
关于股东减持时间过半的进展公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding the progress of a shareholder's stock reduction plan. It details the shares sold, the timing, prices, and compliance with relevant laws and regulations. It does not contain financial statements or detailed financial performance data. The document is focused on shareholder shareholding changes and disclosures related to share reduction activities. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2023-06-21 Chinese
关于使用部分闲置募集资金进行现金管理到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the use of idle raised funds for cash management and the redemption of such investments upon maturity. It details specific financial products purchased with the idle funds, amounts, dates, and returns. The document is relatively short (1683 characters) and focuses on the update of cash management activities related to raised funds, not a full financial report or audit. It does not contain comprehensive financial statements or detailed analysis typical of annual or interim reports. It is an update on financing activities related to the use of raised capital. Therefore, the document fits best under the category 'Capital/Financing Update (CAP)'.
2023-06-06 Chinese
2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2022 annual equity distribution (dividend) plan approved at the 2023 annual general meeting. It details the dividend amount, payment dates, record dates, and the method of distribution to shareholders. It does not contain full financial statements or comprehensive financial performance data, but rather focuses on dividend payment details. The document length is short (1729 characters) and it is clearly an announcement of dividend distribution details following shareholder approval. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2023-05-30 Chinese
拓新药业集团股份有限公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Tuoxin Pharmaceutical Group Co., Ltd. It contains detailed corporate governance rules, shareholder rights and obligations, board and management structure, share issuance and transfer rules, shareholder meeting procedures, and other internal company regulations. It references Chinese company law and securities law, and includes comprehensive provisions on shareholder meetings, board responsibilities, and financial accounting systems. This type of document is a governance charter or internal rules document rather than a financial report, earnings release, or announcement. It is not a report publication announcement or a short notice but a full detailed governance document. Therefore, the appropriate classification is Governance Information (CGR).
2023-05-26 Chinese
关于变更公司名称、住所、经营范围暨完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company regarding changes to its company name, registered address, and business scope, as well as completion of the related business registration procedures. It references board and shareholder meetings where these changes were approved. The document does not contain financial statements, audit information, or detailed financial data. It is a regulatory announcement about corporate changes rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.